PRODUCT OVERVIEW
About PENTINUS® Ointment
Designed around a localized pain-management approach, the formulation is positioned for selected neuropathic and musculoskeletal pain symptoms where topical therapy is appropriate. Its use should follow approved product information and guidance from a qualified healthcare professional.
Composition & Therapeutic Profile
Explore the active ingredients, therapeutic classification and intended focus of PENTINUS® Ointment.
Composition
Gabapentin + Diclofenac Diethylamine + Capsaicin + Methyl Salicylate.
Topical Analgesic Formulation
A multi-modal topical formulation combining ingredients with complementary analgesic and pain-modulating properties.
Therapeutic Focus
Positioned for selected localized neuropathic and musculoskeletal pain symptoms, where topical therapy is clinically appropriate.
How Pentinus Works
PENTINUS® Ointment combines four active ingredients with different pharmacological properties relevant to topical pain management.
Diclofenac diethylamine contributes anti-inflammatory activity, while gabapentin is associated with nerve-related pain modulation. Capsaicin influences sensory nerve signalling, and methyl salicylate contributes topical counter-irritant effects.
The clinical role of the combination depends on the approved product information and the specific context in which it is used.
Anti-inflammatory Activity
Diclofenac diethylamine contributes topical anti-inflammatory activity within the formulation.
Pain-Signal Modulation
Gabapentin and capsaicin have distinct pharmacological actions involving nerve-related pain pathways and sensory signalling.
Local Counter-Irritant Effect
Methyl salicylate contributes a topical counter-irritant effect as part of the formulation.
Clinical & Therapeutic Areas
PENTINUS® Ointment is positioned for localized pain management where topical therapy is clinically appropriate. Its potential role depends on the nature of the symptoms, the approved product indications and professional clinical assessment.
Musculoskeletal Pain
Localized musculoskeletal discomfort where topical analgesic therapy is appropriate.
Neuropathic Pain Symptoms
Selected localized nerve-related pain symptoms, subject to the product's approved indications.
Multimodal Pain Management
A potential component of an individualized pain-management plan guided by a qualified healthcare professional.
Frequently Asked Questions
It is a topical multimodal analgesic formulation containing gabapentin, diclofenac diethylamine, capsaicin and methyl
salicylate.
It is positioned for localized neuropathic and musculoskeletal pain management.
No. Use only as directed on intact skin.
Discover Our Specialty Pharmaceutical Portfolio
Explore the MERGA and PRINCEPS divisions of Seginus Pharma and discover our portfolio of pharmaceutical products across key therapeutic areas.
